| SC 13D/A | 2022-06-07 | GARDNER LEWIS ASSET MANAGEMENT L P | Checkmate Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-06-07 | venBio Global Strategic Fund II L.P. | Checkmate Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2022-06-03 | Novo Holdings A/S | Checkmate Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13D | 2022-06-03 | GARDNER LEWIS ASSET MANAGEMENT L P | Checkmate Pharmaceuticals, Inc. | 1,103,417 | 5.0% | EDGAR |
| SC 13D/A | 2022-05-11 | Novo Holdings A/S | Checkmate Pharmaceuticals, Inc. | 1,828,484 | 8.3% | EDGAR |
| SC 13G/A | 2022-05-05 | venBio Global Strategic Fund II L.P. | Checkmate Pharmaceuticals, Inc. | 2,535,158 | 11.5% | EDGAR |
| SC 13G/A | 2022-02-14 | CLOUGH CAPITAL PARTNERS L P | Checkmate Pharmaceuticals, Inc. | 1,137,764 | 5.3% | EDGAR |
| SC 13G | 2022-02-14 | Decheng Capital Management III (Cayman), LLC | Checkmate Pharmaceuticals, Inc. | 1,333,254 | 6.2% | EDGAR |
| SC 13D/A | 2021-11-01 | Novo Holdings A/S | Checkmate Pharmaceuticals, Inc. | 2,170,100 | 10.0% | EDGAR |
| SC 13G/A | 2021-05-24 | CLOUGH CAPITAL PARTNERS L P | Checkmate Pharmaceuticals, Inc. | 1,552,326 | 7.2% | EDGAR |
| SC 13G/A | 2021-02-12 | CLOUGH CAPITAL PARTNERS L P | Checkmate Pharmaceuticals, Inc. | 1,351,218 | 6.3% | EDGAR |
| SC 13G | 2021-02-12 | Omega Fund VI, L.P. | Checkmate Pharmaceuticals, Inc. | 1,335,050 | 6.2% | EDGAR |
| SC 13G | 2020-11-10 | CLOUGH CAPITAL PARTNERS L P | Checkmate Pharmaceuticals, Inc. | 1,332,397 | 6.2% | EDGAR |
| SC 13G | 2020-10-06 | venBio Global Strategic Fund II L.P. | Checkmate Pharmaceuticals, Inc. | 3,673,374 | 17.1% | EDGAR |
| SC 13D | 2020-08-21 | Longitude Capital Partners III, LLC | Checkmate Pharmaceuticals, Inc. | 1,794,671 | 8.4% | EDGAR |
| SC 13D | 2020-08-19 | Sofinnova Venture Partners IX, L.P. | Checkmate Pharmaceuticals, Inc. | 3,606,707 | 16.8% | EDGAR |
| SC 13G | 2020-08-18 | Medicxi Growth I LP | Checkmate Pharmaceuticals, Inc. | 1,466,869 | 6.8% | EDGAR |
| SC 13D | 2020-08-13 | Novo Holdings A/S | Checkmate Pharmaceuticals, Inc. | 2,170,100 | 10.1% | EDGAR |